Analystreport

Viking Therapeutics, Inc. (NASDAQ: VKTX) was given a new $6.00 price target on by analysts at Roth Capital. They now have a "buy" rating on the stock.

Viking Therapeutics, Inc.  (VKTX) 
Last viking therapeutics, inc. earnings: 4/30 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.vikingtherapeutics.com